Biomea Fusion Inc (BMEA)
8.84
-0.20
(-2.21%)
USD |
NASDAQ |
Nov 04, 16:00
8.84
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Enterprise Value: 239.65M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 239.65M |
| October 31, 2024 | 251.60M |
| October 30, 2024 | 286.76M |
| October 29, 2024 | 349.09M |
| October 28, 2024 | 361.77M |
| October 25, 2024 | 352.35M |
| October 24, 2024 | 330.97M |
| October 23, 2024 | 321.91M |
| October 22, 2024 | 327.70M |
| October 21, 2024 | 319.37M |
| October 18, 2024 | 334.22M |
| October 17, 2024 | 325.89M |
| October 16, 2024 | 329.15M |
| October 15, 2024 | 309.58M |
| October 14, 2024 | 289.29M |
| October 11, 2024 | 302.70M |
| October 10, 2024 | 301.61M |
| October 09, 2024 | 307.05M |
| October 08, 2024 | 325.16M |
| October 07, 2024 | 290.01M |
| October 04, 2024 | 291.83M |
| October 03, 2024 | 277.69M |
| October 02, 2024 | 279.14M |
| October 01, 2024 | 256.31M |
| September 30, 2024 | 278.05M |
| Date | Value |
|---|---|
| September 27, 2024 | 245.20M |
| September 26, 2024 | 233.25M |
| September 25, 2024 | 204.28M |
| September 24, 2024 | 176.40M |
| September 23, 2024 | 185.45M |
| September 20, 2024 | 199.57M |
| September 19, 2024 | 202.10M |
| September 18, 2024 | 201.38M |
| September 17, 2024 | 185.81M |
| September 16, 2024 | 175.67M |
| September 13, 2024 | 170.96M |
| September 12, 2024 | 158.29M |
| September 11, 2024 | 160.46M |
| September 10, 2024 | 161.19M |
| September 09, 2024 | 135.84M |
| September 06, 2024 | 143.08M |
| September 05, 2024 | 162.27M |
| September 04, 2024 | 163.72M |
| September 03, 2024 | 150.69M |
| August 30, 2024 | 152.13M |
| August 29, 2024 | 162.64M |
| August 28, 2024 | 159.74M |
| August 27, 2024 | 170.60M |
| August 26, 2024 | 169.88M |
| August 23, 2024 | 162.27M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-75.96M
Minimum
Apr 29 2022
1.393B
Maximum
Jun 08 2023
266.33M
Average
189.61M
Median
Enterprise Value Benchmarks
| Clearside Biomedical Inc | 46.13M |
| Crinetics Pharmaceuticals Inc | 3.674B |
| NovaBay Pharmaceuticals Inc | 3.615M |
| Palatin Technologies Inc | 13.93M |
| iBio Inc | 9.837M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -32.79M |
| Total Expenses (Quarterly) | 34.04M |
| EPS Diluted (Quarterly) | -0.91 |
| Earnings Yield | -45.36% |